A COMPOUND that slows the proliferation of triple - negative breast cancer cells in lab tests could lead to the first drugs to target this aggressive type of tumour.
IBM's Watson, the supercomputer that famously won the TV quiz Jeopardy! in 2011, is analysing gene sequences from the most aggressivetypesof brain tumours.